Patient-reported burden and overall impact of dry eye disease across eight European countries: a cross-sectional web-based survey

被引:20
作者
Boboridis, Kostas G. [1 ]
Messmer, Elisabeth M. [2 ]
Benitez-del-Castillo, Jose [3 ]
Meunier, Juliette [4 ]
Sloesen, Brigitte [5 ]
O'Brien, Paul [6 ]
Quadrado, Maria Joao [7 ,8 ]
Rolando, Maurizio [9 ]
Labetoulle, Marc [10 ,11 ]
机构
[1] Aristotle Univ Thessaloniki, Dept Ophthalmol 3, Thessaloniki, Greece
[2] Ludwig Maximilians Univ Munchen, Dept Ophthalmol, Munich, Germany
[3] Univ Complutense, Hosp Clin San Carlos, Inst Castroviejo, Clin Rementeria, Madrid, Spain
[4] Modus Outcomes, Lyon, France
[5] Novartis Pharma AG, Dept Ophthalmol, HEOR, Basel, Switzerland
[6] Novartis Ireland Ltd, Dublin, Ireland
[7] Ctr Hosp & Univ Coimbra, Ctr Responsabilidade Integrad Oftalmol, Coimbra, Portugal
[8] Univ Coimbra, Fac Med, Coimbra, Portugal
[9] ISPRE Ophthalm, Ocular Surface & Dry Eye Ctr, Genoa, Italy
[10] Hop Bicetre, AP HP, Ophthalmol, Le Kremlin Bicetre, France
[11] Inserm U1184, Ctr Immunol Viral & Autoimmune Dis IMVA IDMIt, Fontenay Aux Roses, France
关键词
ophthalmology; epidemiology; primary care; corneal and external diseases; public health; OPHTHALMIC SOLUTION 5.0-PERCENT; WORK PRODUCTIVITY LOSS; QUALITY-OF-LIFE; RISK-FACTORS; LIFITEGRAST; PREVALENCE; SYMPTOMS; SUBCOMMITTEE; EPIDEMIOLOGY; POPULATION;
D O I
10.1136/bmjopen-2022-067007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Dry eye disease (DED) is a multifactorial disease involving the tears and ocular surface. It impacts a patient's quality of life (QoL) and ability to perform daily activities. This study assessed the burden of self-reported DED among adults in eight European countries. Design Online cross-sectional survey. Setting General population in France, Italy, Germany, Greece, the Netherlands, Portugal, Spain and Sweden. Participants Adults aged >= 18 years with (n=6084) and without (n=6161) self-reported DED were recruited via emails and screened. Main outcome measures All participants completed National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) and EuroQol-5 Dimension-5 Level Questionnaire (EQ-5D-5L). All DED participants completed the Eye Dryness Score (EDS) Visual Analogue Scale, and Ocular Comfort Index and Work Productivity and Activity Impairment Questionnaire: Specific Health Problem questionnaires. In addition, half of the respondents with DED completed Survey A (Impact of Dry Eye on Everyday Life) and the other half completed Survey B (Standard Patient Evaluation of Eye Dryness Questionnaire) and Dry Eye Questionnaire-5. Results Participants with self-reported DED had lower functional vision and lower overall health status than participants without self-reported DED as measured by the NEI-VFQ and EQ-5D-5L, respectively.Increasing self-reported DED severity as measured by the EDS was shown to correspond with worse symptom severity/frequency, lower functional vision, higher impact on work productivity, daily activities and QoL. Conclusion This study showed that patients' reported burden of self-reported DED was similar across the eight European countries. Those with self-reported DED reported lower health status and functional vision compared to those without self-reported DED and these parameters worsen with increasing disease severity.
引用
收藏
页数:10
相关论文
共 33 条
[1]   Preliminary report of improved sleep quality in patients with dry eye disease after initiation of topical therapy [J].
Ayaki, Masahiko ;
Toda, Ikuko ;
Tachi, Naoko ;
Negishi, Kazuno ;
Tsubota, Kazuo .
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 :329-337
[2]   Diagnosing the severity of dry eye: a clear and practical algorithm [J].
Baudouin, Christophe ;
Aragona, Pasquale ;
Van Setten, Gysbert ;
Rolando, Maurizio ;
Irkec, Murat ;
Benitez del Castillo, Jose ;
Geerling, Gerd ;
Labetoulle, Marc ;
Bonini, Stefano .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (09) :1168-1176
[3]   Dry eye disease ranking among common reasons for seeking eye care in a large US claims database [J].
Bradley, John L. ;
Stillman, Ipek Ozer ;
Pivneva, Irina ;
Guerin, Annie ;
Evans, Amber M. ;
Dana, Reza .
CLINICAL OPHTHALMOLOGY, 2019, 13 :225-232
[4]   Dry eye disease: The scale of the problem [J].
Brewitt, H ;
Sistani, F .
SURVEY OF OPHTHALMOLOGY, 2001, 45 :S199-S202
[5]  
Caffery Barbara, 2011, ARVO Annual Meeting Abstract Search and Program Planner, V2011, P3850
[6]   The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists [J].
Clegg, John P. ;
Guest, Julian F. ;
Lehman, Almut ;
Smith, Andrew F. .
OPHTHALMIC EPIDEMIOLOGY, 2006, 13 (04) :263-274
[7]   Patient-Reported Burden of Dry Eye Disease in the United States: Results of an Online Cross-Sectional Survey [J].
Dana, Reza ;
Meunier, Juliette ;
Markowitz, Jessica T. ;
Joseph, Corey ;
Siffel, Csaba .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2020, 216 :7-17
[8]   A Pragmatic Approach to Dry Eye Diagnosis: Evidence into Practice [J].
Downie, Laura E. ;
Keller, Peter R. .
OPTOMETRY AND VISION SCIENCE, 2015, 92 (12) :1189-1197
[9]   Impaired functional status in primary Sjogren's syndrome [J].
Hackett, Katie L. ;
Newton, Julia L. ;
Frith, James ;
Elliott, Chris ;
Lendrem, Dennis ;
Foggo, Heather ;
Edgar, Suzanne ;
Mitchell, Sheryl ;
Ng, Wan-Fai .
ARTHRITIS CARE & RESEARCH, 2012, 64 (11) :1760-1764
[10]   Lifitegrast for the Treatment of Dry Eye Disease Results of a Phase III, Randomized, Double-Masked, Placebo-Controlled Trial (OPUS-3) [J].
Holland, Edward J. ;
Luchs, Jodi ;
Karpecki, Paul M. ;
Nichols, Kelly K. ;
Jackson, Mitchell A. ;
Sall, Kenneth ;
Tauber, Joseph ;
Roy, Monica ;
Raychaudhuri, Aparna ;
Shojaei, Amir .
OPHTHALMOLOGY, 2017, 124 (01) :53-60